Dr Reddy's shares slump 8.5%; m-cap dips Rs 4,746 crore
The stock fell on reports that the US Food and Drug Administration (USFDA) might withhold approval of the company's fresh drugs and stop import after it found several violations at three of its plants.
Nov 26, 2015, 18:28 PM ISTDr Reddy's Lab launches duloxetine delayed-release capsules
Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market.
Jun 27, 2014, 15:46 PM IST